Cargando…

P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA

Detalles Bibliográficos
Autores principales:	LI, Zengping, Wu, Runhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429981/ http://dx.doi.org/10.1097/01.HS9.0000973352.39161.d6

Ejemplares similares

P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A
por: Xue, F., et al.
Publicado: (2022)

View of Heidelberg in 1619
Publicado: (1941)

Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII
por: Demers, Melanie, et al.
Publicado: (2022)

Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa
por: Lissitchkov, Toshko, et al.
Publicado: (2023)

Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro
por: Takeyama, Masahiro, et al.
Publicado: (2020)

Las Alarmantes Implicaciones del Proyecto 1619
por: Meier, Thomas
Publicado: (2022)

Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant)
por: Ueda, Hitoshi, et al.
Publicado: (2020)

Recombinant follitropin alfa/lutropin alfa in fertility treatment
por: Gibreel, Ahmed, et al.
Publicado: (2010)

African and Native American foodways and resilience: From 1619 to COVID-19
por: Lunsford, Lindsey, et al.
Publicado: (2021)

1619. Carbapenemase Producing Enterobacteriaceae in River Estuaries and Coastal Water of Netanya, Israel
por: Cohen, Regev, et al.
Publicado: (2019)

P1619: PLATELET TRANSFUSION THRESHOLDS FOR PEDIATRIC PATIENTS; ARE WE FALLOWING THE GUIDELINE?
por: Alsulami, H.
Publicado: (2022)

Intermediate 90m Optics for ATLAS-ALFA
por: Burkhardt, H, et al.
Publicado: (2011)

De Venarum Ostiolis 1603 of Hieronymus Fabricius of Aquapendente (1533?-1619) Facsimile Edition
por: Burr, H. S.
Publicado: (1934)

New Hypothesis for Cause of Epidemic among Native Americans, New England, 1616–1619
por: Marr, John S., et al.
Publicado: (2010)

Final Results of the Prospective ADVATE(®) Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII
por: Shapiro, Amy D, et al.
Publicado: (2021)

SCT Barrel
por: Marcelloni Oliveira, C
Publicado: (2005)

SCT barrel
por: Marcelloni Oliveira, C
Publicado: (2005)

Commissioning of the SCT
por: Hayward, H
Publicado: (2008)

The nervous system in colours: the tabulae pictae of G.F. d’Acquapendente (ca. 1533–1619)
por: Zanchin, G., et al.
Publicado: (2006)

1619. Meta-analysis of Randomized Control Trials Evaluating New Beta-Lactamase Combination Antibiotics
por: Wilson, Geneva M, et al.
Publicado: (2020)

Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate(®)) in hemophilia A
por: Chowdary, Pratima, et al.
Publicado: (2016)

Pesticides Use Practice by Market Gardeners in Lome (Togo)
por: Diallo, Aboudoulatif, et al.
Publicado: (2020)

800 MeV RF recombination: trajectories, optics, commissioning
por: Schindl, K
Publicado: (1984)

Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study
por: Malec, Lynn, et al.
Publicado: (2023)

Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
por: Lorenzoni, Valentina, et al.
Publicado: (2018)

Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study
por: Escuriola Ettingshausen, Carmen, et al.
Publicado: (2021)

Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C
por: Napolitano, Mariasanta, et al.
Publicado: (2021)

BK(Ca) Activator NS1619 Improves the Structure and Function of Skeletal Muscle Mitochondria in Duchenne Dystrophy
por: Dubinin, Mikhail V., et al.
Publicado: (2022)

Mortality associated with cardiovascular diseases in three hospitals of Lomé-city
por: Damorou, Findibe, et al.
Publicado: (2011)

Assessing Market-Sold Remedies in Lomé (Togo) for Hygienic Quality
por: de Souza, Comlan, et al.
Publicado: (2010)

Epidémiologie et étiologies des insuffisances cardiaques à Lomé
por: Pio, Machihudé, et al.
Publicado: (2014)

Acne in Lomé, Togo: clinical aspects and quality of life of patients
por: Saka, Bayaki, et al.
Publicado: (2018)

Diversity of Ants and Termites of the Botanical Garden of the University of Lomé, Togo
por: Kasseney, Boris Dodji, et al.
Publicado: (2019)

Quality of Long-acting Reversible Contraception Provision in Lomé, Togo
por: Weidert, Karen, et al.
Publicado: (2020)

Redundancy and Synchronisation in the SCT
por: Nickerson, R B, et al.
Publicado: (1996)

Redundancy and Synchronisation in the SCT
por: Nickerson, R B, et al.
Publicado: (1996)

Status of the ATLAS SCT
por: Clark, Allan, et al.
Publicado: (2007)

ATLAS SCT Commissioning
por: Limper, Maaike
Publicado: (2007)

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
por: Nawroth, Frank, et al.
Publicado: (2015)

Development and Characterization of Recombinant Ovine Coagulation Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v4td27c0jea2b0r9lmfd4pjbve